Feb 11 (Reuters) - Immutep Limited:
- IMMUTEP GRANTED AUSTRALIAN PATENT FOR EFTILAGIMOD ALPHA, A SOLUBLE LAG-3 PROTEIN, IN COMBINATION WITH A PD-1 PATHWAY INHIBITOR
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
25.3¢ |
Change
0.003(1.00%) |
Mkt cap ! $370.6M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 25.0¢ | $216.9K | 852.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 433747 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 151711 | 20 |
View Market Depth
| Last trade - 12.27pm 19/09/2025 (20 minute delay) ? |
| IMM (ASX) Chart |